Digital
Trustworthy and novel AI in clinical trial planning, with Kr...
Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials
R&D
Changing Faces: Pharma and biotech, April 2026
April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
Sales & Marketing
Sponsored
Solution Spotlight: InConcert for pre-launch
Inizio InConcert brings together engagement data, field insight, and clinical indicators to help teams see how readiness is taking shape.
Digital
The NHS 10-Year Plan will only succeed if digital health mee...
The NHS 10-Year Plan defines three core pillars that are set to revolutionise how we receive care.
R&D
Why UCB bet a billion dollars on cell therapy for epilepsy
UCB's chief science officer spoke to pharmaphorum about why Neurona's in-development cell therapy could be a game changer for epilepsy treatment.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
